Nachrichten zur Teva Pharmaceutical Industries Ltd. ADR Aktie

Insiderhandel: Executive VP Global Operations verkauft Aktien von Teva Pharma Industries im Wert von 333.030$

Drape, Eric - Vorstand - Tag der Transaktion: 2023-02-28...…

Insiderhandel: Exec. VP Chief Legal Officer verkauft Aktien von Teva Pharma Industries im Wert von 626.642$

Stark, David Matthew - Vorstand - Tag der Transaktion: 2023-02-28...…

Insiderhandel: EVP, North America Commercial verkauft Aktien von Teva Pharma Industries im Wert von 589.785$

Dethlefs, Sven - Vorstand - Tag der Transaktion: 2023-02-28...…

Insiderhandel: Exec. VP, European Commercial verkauft Aktien von Teva Pharma Industries im Wert von 437.502$

Daniell, Richard - Vorstand - Tag der Transaktion: 2023-02-28...…

Teva announces debt recycling measures

The Israeli pharmaceutical company is to issue $2.06 billion of sustainability-linked senior notes and has begun tender offers to purchase…

Teva to raise $2.06B in sustainability-linked senior notes offering, launches $2.25B in debt tender offers for notes

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Teva Announces $2.06 Bln Senior Notes Offering, $2.25 Bln Debt Tender Offers For Notes

PETAH TIKVA (dpa-AFX) - Teva Pharmaceutical Industries Ltd. (TEVA) announced Monday its intention to issue $2.06 billion equivalent of sustainability-linked…

Teva: Was Deutschland-Chef Andreas Burkhardt am snowboarden so liebt

Snowboarder sitzen nur am Hang rum und schieben den Schnee nach unten? Mit diesem Vorurteil kann Andreas Burkhardt, Deutschland-Chef von…

Teva Gets FDA Approval for Movement Disorders Treatment

Teva Gets FDA Approval for Movement Disorders Treatment...…

Protein Inhibitors Global Market Report 2023

NEW YORK, Feb. 16, 2023 /PRNewswire/ -- Major players in the protein inhibitors market are Bayer AG, Astra Zeneca, Roche,…

Teva Unveils Spring 2023 Collection

GOLETA, Calif., Feb. 16, 2023 /PRNewswire/ -- Teva®, a division of Deckers Brands (NYSE: DECK), announces the arrival of its…

Global Digital Respiratory Devices Market Report to 2030 - Featuring Cohero Health, Cognita Labs, Adherium, Amiko Digital Health and Teva Pharmaceuticals Industries Among Others

DUBLIN, Feb. 13, 2023 /PRNewswire/ -- The "Digital Respiratory Devices Market Size, Share & Trends Analysis Report by Product (Smart…

Rituximab Biosimilars Global Market Report 2023

NEW YORK, Feb. 13, 2023 /PRNewswire/ -- Major players in the rituximab biosimilars market are Pfizer Inc., Mylan Inc., Amgen…

Axsome slips as Teva seeks generic for depression therapy

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 10-K TEVA PHARMACEUTICAL INDU For: Dec 31

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

TEVA Pharmaceutical: Kursziel gesteigert

London (www.aktiencheck.de) - Rating-Update: Balaji Prasad, Analyst von Barclays, bestätigt das Rating "overweight" für die Aktie von TEVA Pharmaceutical Industries Ltd.…

Teva Pharma Agrees To Settle Price-Fixing Claims With Florida

PETAH TIKVA (dpa-AFX) - Teva Pharmaceutical Industries Ltd. (TEVA) announced Thursday that its U.S. affiliate Teva Pharma signed an agreement…

Teva to pay ~$6.7M to Florida to settle price fixing claims

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Teva Pharmaceutical Industries (TEVA) Q4 2022 Earnings Call Transcript

TEVA earnings call for the period ending December 31, 2022....…

UPDATE 2-Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints

... JERUSALEM, Feb 8 (Reuters) - Teva Pharmaceutical Industries, the worlds......…

Teva reports heavy losses, sees minimal 2023 growth

New Teva CEO Richard Francis: We continued to optimize our supply chain and manufacturing capabilities and reduced our net debt....…

Teva issues in line guidance as North American revenue remains flat

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

ROUNDUP: Teva Issues FY23 Adj. Earnings, Revenue Outlook

PETAH TIKVA (dpa-AFX) - Teva Pharmaceutical Industries Limited (TEVA), while announcing sharply wider net loss and weak revenues in its…

Teva Pharmaceutical Industries Limited Q4 Earnings Summary

PETAH TIKVA (dpa-AFX) - Below are the earnings highlights for Teva Pharmaceutical Industries Limited (TEVA):Earnings: -$1.22 billion in Q4 vs.…

Teva Pharm Q4 profit meets estimates, revenue slips

...JERUSALEM (Reuters) - Israel-based Teva Pharmaceutical Industries......…

Form 8-K TEVA PHARMACEUTICAL INDU For: Feb 08

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Teva follows AbbVie to leave top pharma industry group

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Catalyst Pharma Down 34% as Teva Eyes Generic Version of Firdapse

Catalyst Pharma Down 34% as Teva Eyes Generic Version of Firdapse...…

Why Catalyst Pharmaceuticals Shares Are Moving

Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) shares are trading lower by 13.46% to $18.00 Monday morning after Teva Pharmaceuticals stated it…

Teva Seeks FDA OK for Generic Form of Catalysts Firdapse

Teva Seeks FDA OK for Generic Form of Catalyst's Firdapse...…

Catalyst stock slumps ~20% as Teva seeks FDA approval of generic Firdapse

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Catalyst Pharmaceuticals Notified of Abbreviated New Drug Application Filing for FIRDAPSE®

CORAL GABLES, Fla., Jan. 23, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (NASDAQ: CPRX), a commercial-stage biopharmaceutical…

Teva trades lower after Jefferies cuts rating to Hold

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

TEVA Shares Rise on Broad Support for Opioids Settlement

With the required participation from states and local governments, TEVA can now move forward with the nationwide settlement....…

Teva: 48 US states have agreed to opioid settlement

The Israeli pharmaceutical company said that a sufficient level of participation in the settlement had been reached to allow it…

Teva Pharmaceutical says 48 states have agreed to its opioid settlement

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Teva Pharmaceutical Industries Ltd. (TEVA) Stock Jumps 5.5%: Will It Continue to Soar?

Teva Pharmaceutical Industries Ltd. (TEVA) witnessed a jump in share price last session on above-average trading volume. The latest trend…

Teva Pharma Confirms Participation From 48 States On Opioids Settlement

PETAH TIKVA (dpa-AFX) - Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), confirmed a sufficient level of…

UPDATE 1-Teva says opioids settlement to move forward in U.S.

...(Adds details and background) Jan 9 (Reuters) - Israeli drugmaker......…

Teva says opioids settlement to move forward in U.S

...(Reuters) - Israeli drugmaker Teva Pharmaceutical Industries Ltd......…

Teva says opioids settlement to move forward in U.S.

...Jan 9 (Reuters) - Israeli drugmaker Teva Pharmaceutical Industries......…

Alvotech, Teva Shares Rise After FDA Accepts BLA for AVT04

Alvotech, Teva Shares Rise After FDA Accepts BLA for AVT04...…

Alvotech: FDA Accepts BLA For AVT04, Proposed Biosimilar To Stelara

PETAH TIKVA (dpa-AFX) - Alvotech (ALVO) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), said that…

Alvotech and Teva Announce Acceptance of U.S. Biologics License Application for AVT04, a Proposed Biosimilar to Stelara® (ustekinumab)

REYKJAVIK, Iceland and PARSIPPANY, N.J., Jan. 06, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company…

Epinephrine autoinjector market to grow at 8.07% Y-O-Y in 2023; Increasing prevalence of allergies will drive growth -Technavio

NEW YORK, Dec. 19, 2022 /PRNewswire/ -- Epinephrine autoinjector market insights - Vendors: 15+, including Adamis Pharmaceuticals Corp., ALK Abello…

dpa-AFX ProFeed